Current Pharmaceutical Design

Preface
pp. i-i(1)
Author: Jirillo, E.

Treatment of Chronic Hepatitis B
pp. 953-958(6)
Authors: Lagget, M.; Rizzetto, M.

New Therapies for the Treatment of Chronic Hepatitis C
pp. 959-966(8)
Authors: Ideo, G.; Bellobuono, A.

The Treatment of Chronic Hepatitis C not Responding to Interferon
pp. 967-975(9)
Authors: Cozzolongo, R.; Cupone, R.; Manghisi, O.G.

Incidence of Side Effects During Therapy with Different Types of Alpha Interferon: A Randomised Controlled Trial Comparing Recombinant Alpha 2b Versus Leukocyte Interferon in the Therapy of Naive Patients with Chronic Hepatitis C
pp. 977-980(4)
Authors: Ascione, A.; Luca, M.; Costanzo, G.; Picciotto, F.; Lanza, A.; Canestrini, C.; Morisco, F.; Tuccillo, C.; Caporaso, N.

Modifications of the Immune Responsiveness in Patients with Hepatitis C Virus Infection following Treatment with IFN-α / Ribavirin
pp. 981-993(13)
Authors: Amati, L.; Caradonna, L.; Magrone, T.; Mastronardi, M.L.; Cuppone, R.; Cozzolongo, R.; Manghisi, O.G.; Caccavo, D.; Amoroso, A.; Jirillo, E.

Biological and Clinical Significance of Endotoxemia in the Course of Hepatitis C Virus Infection
pp. 995-1005(11)
Authors: Caradonna, L.; Mastronardi, M.L.; Magrone, T.; Cozzolongo, R.; Cuppone, R.; Manghisi, O.G.; Caccavo, D.; Pellegrino, N.M.; Amoroso, A.; Jirillo, E.; Amati, L.

Main Characteristics of Hepatocellular Carcinoma and Cirrhosis and Therapeutic Approaches
pp. 1007-1011(5)
Authors: Elba, S.; Buongiorno, G.P.; Caruso, M.L.; Noviello, M.R.; Manghisi, O.G.

Tamoxifen in the Treatment of Hepatocellular Carcinoma: 5-Year Results of the CLIP-1 Multicentre Randomised Controlled Trial
pp. 1013-1019(7)
Authors: Perrone, F.; Gallo, C.; Daniele, B.; Gaeta, G.B.; Izzo, F.; Capuano, G.; Adinolfi, L.E.; Mazzanti, R.; Farinati, F.; Elba, S.; Piai, G.; Calandra, M.; Stanzione, M.; Mattera, D.; Aiello, A.; de Sio, I.; Castiglione, F.; Russo, M.; Persico, M.; Felder, M.; Manghisi, O.G.; de Maio, E.; Di Maio, M.; Pignata, S.